Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CME GroupWBO:CMEG -1.19%83 Piotroski F-Score is 4 as of Jul. 30, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates WBO:CMEG with a GF Score™ of 83/100 and a GF Value™ of €241.59 (Fairly Valued). The stock has 3 warning signs investors should review. Among 782 Capital Markets companies, CME Group ranks worse than 56.78% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
CME Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for CME Group's Piotroski F-Score or its related term are showing as below:
WBO:CMEG'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 5 Max: 7
Current: 4
During the past 13 years, the highest Piotroski F-Score of CME Group was 7. The lowest was 3. And the median was 5.
CME Group (WBO:CMEG) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
CME Group Piotroski F-Score Related Terms
CME Group Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for CME Group's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:CMEG vs ICE, MCO, SPGI: Piotroski F-Score Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Piotroski F-Score vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where CME Group's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 773.616 + 1010.197 + 998.469 + 904.282 = €3,687 Mil. Cash Flow from Operations was 824.821 + 968.351 + 1089.813 + 822.083 = €3,705 Mil. Revenue was 1310.035 + 1407.99 + 1626.286 + 1480.982 = €5,825 Mil. Gross Profit was 1107.6 + 1202.09 + 1433.391 + 1278.304 = €5,021 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(155979.369 + 159447.199 + 169454.267 + 174724.377 + 168979.289) / 5 = €165716.9002 Mil. Total Assets at the begining of this year (Jun25) was €155,979 Mil. Long-Term Debt & Capital Lease Obligation was €2,972 Mil. Total Current Assets was €140,296 Mil. Total Current Liabilities was €137,767 Mil.
Net Income was 822.433 + 835.243 + 884.485 + 888.762 = €3,431 Mil.
Revenue was 1427.544 + 1456.662 + 1519.127 + 1466.964 = €5,870 Mil. Gross Profit was 1230.406 + 1245.798 + 1327.93 + 1274.837 = €5,079 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(114619.37 + 124153.385 + 131261.885 + 145994.23 + 155979.369) / 5 = €134401.6478 Mil. Total Assets at the begining of last year (Jun24) was €114,619 Mil. Long-Term Debt & Capital Lease Obligation was €2,965 Mil. Total Current Assets was €126,105 Mil. Total Current Liabilities was €123,803 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
CME Group's current Net Income (TTM) was 3,687.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
CME Group's return on assets of this year was 0.02363495. CME Group's return on assets of last year was 0.02993319.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
CME Group's gearing of this year was 0.01793544. CME Group's gearing of last year was 0.02206436.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
CME Group's current ratio of this year was 1.01835843. CME Group's current ratio of last year was 1.01859521.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
CME Group's number of shares in issue this year was 361.282. CME Group's number of shares in issue last year was 360.355.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
CME Group's gross margin of this year was 0.86199698. CME Group's gross margin of last year was 0.8651983.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
CME Group's asset turnover of this year was 0.03734656. CME Group's asset turnover of last year was 0.05121558.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
0
+
0
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
CME Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.
CME Group (WBO:CMEG) has a Piotroski F-Score of 4 as of Jul. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on CME Group and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, CME Group's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, CME Group ranks #444 out of 782 companies in the Capital Markets industry, placing it in the top 56.8%.
Is CME Group's Piotroski F-Score too high?
CME Group's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Capital Markets industry median Piotroski F-Score is 5.00. CME Group's value of 4 is 20% below this industry median. Based on the distribution chart, CME Group ranks #444 out of 782 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Piotroski F-Score compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #444 out of 782 companies for Piotroski F-Score. This places CME Group in the lower half of its industry. The industry median Piotroski F-Score is 5.00. CME Group's value of 4 is 20% below this benchmark. Historically, CME Group's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, CME Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Capital Markets company?
The median Piotroski F-Score among Capital Markets companies is 5.00, based on 782 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (WBO:CMEG) is currently considered Fairly Valued. The stock's GF Value™ is €241.59, compared to a current price of €229.10 — trading 5.2% below its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Capital Markets industry median of 5.00. CME Group's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For CME Group (WBO:CMEG), the current Piotroski F-Score is 4 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (WBO:CMEG) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of €229.10 is trading 5.2% below its estimated GF Value™ of €241.59.
GuruFocus considers CME Group to be Fairly Valued.
Key valuation signals for WBO:CMEG:
Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
GF Value™: €241.59 vs. price of €229.10 (5.2% below fair value)
Industry Position: 20% below the Capital Markets median (#444 of 782)
No single metric tells the full story. See the WBO:CMEG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
83GF Score
Get the complete analysis for WBO:CMEG
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CMEG has been successfully added to your 
